ID   GMPPB_HUMAN             Reviewed;         360 AA.
AC   Q9Y5P6; A8K6N5; Q9H7U3;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   04-FEB-2015, entry version 121.
DE   RecName: Full=Mannose-1-phosphate guanyltransferase beta;
DE            EC=2.7.7.13;
DE   AltName: Full=GDP-mannose pyrophosphorylase B;
DE   AltName: Full=GTP-mannose-1-phosphate guanylyltransferase beta;
GN   Name=GMPPB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT ARG-184.
RA   Matthijs G., Schollen E., Dierickx D.;
RT   "Human homolog of GDP-mannose pyrophosphorylase.";
RL   Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   ARG-184.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R.,
RA   Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R.,
RA   Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V.,
RA   Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R.,
RA   Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Wei S.,
RA   Wheeler D.A., Wright M.W., Worley K.C., Yuan Y., Zhang Z., Adams C.Q.,
RA   Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clendenning J., Clerc-Blankenburg K.P., Chen R., Chen Z., Davis C.,
RA   Delgado O., Dinh H.H., Dong W., Draper H., Ernst S., Fu G.,
RA   Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., Hao B.,
RA   Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., Jackson L.R.,
RA   Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., Liu J.,
RA   Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Palmeiri A.,
RA   Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J.,
RA   Zhang X., Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H.,
RA   Reinhardt R., Naylor S.L., Yang H., Olson M., Weinstock G.,
RA   Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-184.
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [7]
RP   SUBCELLULAR LOCATION, VARIANT MDDGA14 ASN-334, VARIANTS MDDGB14
RP   LEU-32; CYS-185 AND GLN-287, VARIANTS MDDGC14 SER-22; HIS-27 AND
RP   ILE-330, CHARACTERIZATION OF VARIANT MDDGA14 ASN-334, CHARACTERIZATION
RP   OF VARIANTS MDDGB14 LEU-32; CYS-185 AND GLN-287, AND CHARACTERIZATION
RP   OF VARIANTS MDDGC14 SER-22; HIS-27 AND ILE-330.
RX   PubMed=23768512; DOI=10.1016/j.ajhg.2013.05.009;
RG   UK10K Consortium;
RA   Carss K.J., Stevens E., Foley A.R., Cirak S., Riemersma M.,
RA   Torelli S., Hoischen A., Willer T., van Scherpenzeel M., Moore S.A.,
RA   Messina S., Bertini E., Boennemann C.G., Abdenur J.E., Grosmann C.M.,
RA   Kesari A., Punetha J., Quinlivan R., Waddell L.B., Young H.K.,
RA   Wraige E., Yau S., Brodd L., Feng L., Sewry C., MacArthur D.G.,
RA   North K.N., Hoffman E., Stemple D.L., Hurles M.E., van Bokhoven H.,
RA   Campbell K.P., Lefeber D.J., Lin Y.Y., Muntoni F.;
RT   "Mutations in GDP-mannose pyrophosphorylase B cause congenital and
RT   limb-girdle muscular dystrophies associated with hypoglycosylation of
RT   alpha-dystroglycan.";
RL   Am. J. Hum. Genet. 93:29-41(2013).
CC   -!- CATALYTIC ACTIVITY: GTP + alpha-D-mannose 1-phosphate =
CC       diphosphate + GDP-mannose.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; GDP-alpha-D-mannose
CC       biosynthesis; GDP-alpha-D-mannose from alpha-D-mannose 1-phosphate
CC       (GTP route): step 1/1.
CC   -!- SUBUNIT: Associates with GMPPA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:23768512}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9Y5P6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y5P6-2; Sequence=VSP_028619;
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       brain and eye anomalies A14 (MDDGA14) [MIM:615350]: An autosomal
CC       recessive disorder characterized by congenital muscular dystrophy
CC       associated with brain anomalies, eye malformations, and profound
CC       mental retardation. The disorder includes a severe form designated
CC       as Walker-Warburg syndrome and a less severe phenotype known as
CC       muscle-eye-brain disease. MDDGA14 features include increased
CC       muscle tone, microcephaly, cleft palate, feeding difficulties,
CC       severe muscle weakness, sensorineural hearing loss, cerebellar
CC       hypoplasia, ataxia, and retinal dysfunction.
CC       {ECO:0000269|PubMed:23768512}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy congenital with
CC       mental retardation B14 (MDDGB14) [MIM:615351]: A congenital
CC       muscular dystrophy characterized by severe muscle weakness
CC       apparent in infancy and mental retardation. Some patients may have
CC       additional features, such as microcephaly, cardiac dysfunction,
CC       seizures, or cerebellar hypoplasia. {ECO:0000269|PubMed:23768512}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Muscular dystrophy-dystroglycanopathy limb-girdle C14
CC       (MDDGC14) [MIM:615352]: An autosomal recessive form of muscular
CC       dystrophy characterized by mild proximal muscle weakness with
CC       onset in early childhood. Some patients may have additional
CC       features, such as mild intellectual disability or seizures.
CC       {ECO:0000269|PubMed:23768512}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the transferase hexapeptide repeat family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF135421; AAD38516.1; -; mRNA.
DR   EMBL; AK024319; BAB14882.1; -; mRNA.
DR   EMBL; AK291700; BAF84389.1; -; mRNA.
DR   EMBL; AC099668; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC001141; AAH01141.1; -; mRNA.
DR   EMBL; BC008033; AAH08033.1; -; mRNA.
DR   CCDS; CCDS2802.1; -. [Q9Y5P6-2]
DR   CCDS; CCDS2803.1; -. [Q9Y5P6-1]
DR   RefSeq; NP_037466.2; NM_013334.3.
DR   RefSeq; NP_068806.1; NM_021971.2.
DR   UniGene; Hs.567488; -.
DR   ProteinModelPortal; Q9Y5P6; -.
DR   SMR; Q9Y5P6; 1-333.
DR   BioGrid; 118966; 22.
DR   IntAct; Q9Y5P6; 1.
DR   MINT; MINT-1461031; -.
DR   STRING; 9606.ENSP00000309092; -.
DR   PhosphoSite; Q9Y5P6; -.
DR   DMDM; 160013885; -.
DR   MaxQB; Q9Y5P6; -.
DR   PaxDb; Q9Y5P6; -.
DR   PRIDE; Q9Y5P6; -.
DR   Ensembl; ENST00000308375; ENSP00000309092; ENSG00000173540. [Q9Y5P6-2]
DR   Ensembl; ENST00000308388; ENSP00000311130; ENSG00000173540. [Q9Y5P6-1]
DR   Ensembl; ENST00000480687; ENSP00000418565; ENSG00000173540. [Q9Y5P6-1]
DR   GeneID; 29925; -.
DR   KEGG; hsa:29925; -.
DR   UCSC; uc003cxk.1; human. [Q9Y5P6-1]
DR   UCSC; uc003cxl.1; human. [Q9Y5P6-2]
DR   CTD; 29925; -.
DR   GeneCards; GC03M049754; -.
DR   HGNC; HGNC:22932; GMPPB.
DR   HPA; HPA014657; -.
DR   MIM; 615320; gene.
DR   MIM; 615350; phenotype.
DR   MIM; 615351; phenotype.
DR   MIM; 615352; phenotype.
DR   neXtProt; NX_Q9Y5P6; -.
DR   Orphanet; 363623; Autosomal recessive limb-girdle muscular dystrophy type 2T.
DR   Orphanet; 370959; Congenital muscular dystrophy with cerebellar involvement.
DR   Orphanet; 370968; Congenital muscular dystrophy with intellectual disability.
DR   Orphanet; 588; Muscle-eye-brain disease.
DR   PharmGKB; PA134875590; -.
DR   eggNOG; COG1208; -.
DR   GeneTree; ENSGT00530000063581; -.
DR   HOGENOM; HOG000283479; -.
DR   HOVERGEN; HBG107955; -.
DR   InParanoid; Q9Y5P6; -.
DR   KO; K00966; -.
DR   OMA; EVRMENV; -.
DR   OrthoDB; EOG7CRTPW; -.
DR   PhylomeDB; Q9Y5P6; -.
DR   TreeFam; TF300718; -.
DR   Reactome; REACT_22423; Synthesis of GDP-mannose.
DR   UniPathway; UPA00126; UER00930.
DR   ChiTaRS; GMPPB; human.
DR   GeneWiki; GMPPB; -.
DR   GenomeRNAi; 29925; -.
DR   NextBio; 52539; -.
DR   PRO; PR:Q9Y5P6; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; Q9Y5P6; -.
DR   CleanEx; HS_GMPPB; -.
DR   ExpressionAtlas; Q9Y5P6; baseline and differential.
DR   Genevestigator; Q9Y5P6; -.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular vesicular exosome; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004475; F:mannose-1-phosphate guanylyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0009298; P:GDP-mannose biosynthetic process; TAS:Reactome.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0018279; P:protein N-linked glycosylation via asparagine; TAS:Reactome.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR001451; Hexapep_transf.
DR   InterPro; IPR018357; Hexapep_transf_CS.
DR   InterPro; IPR005835; NTP_transferase.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   Pfam; PF00132; Hexapep; 1.
DR   Pfam; PF00483; NTP_transferase; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   PROSITE; PS00101; HEXAPEP_TRANSFERASES; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital muscular dystrophy; Cytoplasm; Disease mutation;
KW   Dystroglycanopathy; GTP-binding; Limb-girdle muscular dystrophy;
KW   Nucleotide-binding; Nucleotidyltransferase; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    360       Mannose-1-phosphate guanyltransferase
FT                                beta.
FT                                /FTId=PRO_0000307162.
FT   VAR_SEQ     317    317       W -> WVSLWAGLGGERGGECACLPDKAYPLLE (in
FT                                isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_028619.
FT   VARIANT      22     22       P -> S (in MDDGC14; causes protein
FT                                aggregation).
FT                                {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070142.
FT   VARIANT      27     27       D -> H (in MDDGC14; the protein remains
FT                                distributed in the cytoplasm and has no
FT                                discernable changes compared to wild-
FT                                type). {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070143.
FT   VARIANT      32     32       P -> L (in MDDGB14; causes protein
FT                                aggregation).
FT                                {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070144.
FT   VARIANT     126    126       H -> D (in dbSNP:rs34345884).
FT                                /FTId=VAR_035372.
FT   VARIANT     184    184       Q -> R (in dbSNP:rs1466685).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.1}.
FT                                /FTId=VAR_035373.
FT   VARIANT     185    185       R -> C (in MDDGB14; the protein remains
FT                                distributed in the cytoplasm and has no
FT                                discernable changes compared to wild-
FT                                type). {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070145.
FT   VARIANT     287    287       R -> Q (in MDDGB14).
FT                                {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070146.
FT   VARIANT     330    330       V -> I (in MDDGC14; causes protein
FT                                aggregation).
FT                                {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070147.
FT   VARIANT     334    334       D -> N (in MDDGA14; causes protein
FT                                aggregation).
FT                                {ECO:0000269|PubMed:23768512}.
FT                                /FTId=VAR_070148.
SQ   SEQUENCE   360 AA;  39834 MW;  8212C77BBB2EF960 CRC64;
     MKALILVGGY GTRLRPLTLS TPKPLVDFCN KPILLHQVEA LAAAGVDHVI LAVSYMSQVL
     EKEMKAQEQR LGIRISMSHE EEPLGTAGPL ALARDLLSET ADPFFVLNSD VICDFPFQAM
     VQFHRHHGQE GSILVTKVEE PSKYGVVVCE ADTGRIHRFV EKPQVFVSNK INAGMYILSP
     AVLQRIQLQP TSIEKEVFPI MAKEGQLYAM ELQGFWMDIG QPKDFLTGMC LFLQSLRQKQ
     PERLCSGPGI VGNVLVDPSA RIGQNCSIGP NVSLGPGVVV EDGVCIRRCT VLRDARIRSH
     SWLESCIVGW RCRVGQWVRM ENVTVLGEDV IVNDELYLNG ASVLPHKSIG ESVPEPRIIM
//
